XTALPI Recognized with Multiple Prestigious Awards Amid IPO Momentum

Since its establishment in 2015,XtalPi (XtalPi Holdings Limited, XTALPI-P, Stock Code: 2228.HK)Continuous R&D investment has deepened technological and industrial innovation, achieving positive results through the deep integration of basic scientific theories and cutting-edge technologies. There have been continuous achievements in the fields of biomedicine, fine chemicals, and new energy, and corporate development has reached a new milestone, entering a new era.

Recently, XtalPi has won multiple prestigious awards, once again gaining recognition and affirmation from both within and outside the industry.

2024 Hurun China Artificial Intelligence Enterprises 50 Strong

Hurun Research Institute, a renowned research institution, released the "2024 Hurun China Top 50 Artificial Intelligence Enterprises," with XtalPi selected for its technological innovation in artificial intelligence and industrial innovation in application implementation.

This is the first time that Hurun Research Institute has released the "Hurun China Top 50 Artificial Intelligence Enterprises" list, which ranks companies based on their value. The list focuses on the artificial intelligence sector and selects the most valuable Chinese AI enterprises by comprehensively evaluating their technological innovation capabilities, commercialization abilities, and market performance, recognizing pioneering companies driving industry transformation.

Asia Finance 2024 Achievement Awards

The internationally authoritative English financial magazine *FinanceAsia* released the 2024 Achievement Awards (FinanceAsia Achievement Awards 2024), and XtalPi was highly commended for the Best IPO of the Year award.

"Asia Financial" is acclaimed as the most representative professional monthly publication in the capital markets of Asia, wielding significant influence in the investment community. Its hosted "Annual Achievement Awards" is one of the most influential and credible industry award selections in the Asia-Pacific region, and is a major annual event in the investment world. The awards aim to recognize significant financial market transactions in the Asia-Pacific region and highlight the achievements of key participants in related fields across the region.

BioCentury-BayHelix Annual Awards

Recently, at the 11th China Healthcare Summit co-hosted by BioCentury and BayHelix, and supported by McKinsey, the BioCentury-BayHelix Annual Awards were unveiled, with XtalPi being awarded the "Commercial Achievement of the Year."

The BioCentury-BayHelix Annual Awards aim to recognize individuals and companies that have achieved outstanding accomplishments and contributions in China's healthcare ecosystem, including the R&D Achievement of the Year, Deal of the Year, Commercial Achievement of the Year, Company of the Year, and Women Leader of the Year awards.

R&D Guest 2024 Annual IPO Award

At the 8th PharmDJ Clinical Annual Conference & ChinaTrials16, PharmDJ, a well-known industry media, announced the 2024 series of annual awards, covering the Clinical Operation Team of the Year Award, Biotech Rising Star of the Year Award, Innovative Drug of the Year Award, IPO of the Year Award, Deal of the Year Award, and Collaboration of the Year Award.

XtalPi Honors the Annual IPO Award, Sharing the Stage with Leading Companies in China's Healthcare Ecosystem and Innovative Drug Sector Such as Eli Lilly China, Roche, Boehringer Ingelheim, and Legend Biotech.

Guangdong-Hong Kong-Macao Greater Bay Area Data Application Innovation Competition

Good news also came from the product side. In the Guangdong-Hong Kong-Macao Greater Bay Area Data Application Innovation Competition (GBA-DataAi), PatSight, an AI drug patent data extraction and analysis platform co-developed by XtalPi and the Greater Bay Area Digital Economy Research Institute, stood out from 400 teams across China, winning the second prize in the special competition (ranking first in the biomedicine direction).

2024 Hurun U40 China Entrepreneurial Pioneer

Hurun Research Institute recently released the "Hurun China Under40s 2024," aiming to identify pioneering entrepreneurs in China aged 40 and under. This is the second time that Hurun Research Institute has published this list. Dr. Ma Jian and Dr. Lai Libo, co-founders of XtalPi, were both selected.